CoChat

Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations

Open access
Stam, Anine H., Kothari, Parul H., Shaikh, Aisha, Gschwendter, Andreas, Jen, Joanna C., Hodgkinson, Suzanne, Hardy, Todd A., Hayes, Michael, Kempster, Peter A., Kotschet, Katya E., Bajema, Ingeborg M., van Duinen, Sjoerd G., Maat-Schieman, Marion L. C., de Jong, Paulus T. V. M., de Smet, Marc D., de Wolff-Rouendaal, Didi, Dijkman, Greet, Pelzer, Nadine, Kolar, Grant R., Schmidt, Robert E., Lacey, JoAnne, Joseph, Daniel, Fintak, David R., Grand, M. Gilbert, Brunt, Elizabeth M., Liapis, Helen, Hajj-Ali, Rula A., Kruit, Mark C., van Buchem, Mark A., Dichgans, Martin, Frants, Rune R., van den Maagdenberg, Arn M. J. M., Haan, Joost, Baloh, Robert W., Atkinson, John P., Terwindt, Gisela M., Ferrari, Michel D. · 2016 · Brain
Cited by 174

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

See Charidimou (doi:10.1093/aww253) for a scientific commentary on this article. Cerebroretinal vasculopathy, hereditary vascular retinopathy, and hereditary endotheliopathy, retinopathy, nephropathy and stroke are neurovascular syndromes initially described as distinct entities. Recently they were shown to be one disease caused by C-terminal frame-shift mutations in TREX1, which was termed ‘retinal vasculopathy with cerebral leukodystrophy’. Here we defined the genetic and clinicopathologic spectrum of this clinically and pathophysiologically poorly characterized and frequently misdiagnosed fatal neurovascular disorder. We identified five different TREX1 mutations in 78 members from 11 unrelated families and by using a standardized study protocol we retrospectively reviewed and aggregated the associated clinical, neuroimaging, and pathology data. Findings were similar across mutations and families. Sixty-four mutation carriers had vascular retinopathy. Neuroimaging revealed (i) punctate, hyperintense, white matter lesions with or without nodular enhancement in 97% of them; (ii) rim-enhancing mass lesions in 84%; and (iii) calcifications in the white matter in 52%. Ninety per cent had clinical manifestations of brain disease, including focal neurological deficits (68%), migraine (59%), cognitive impairment (56%), psychiatric disturbances (42%), and seizures (17%). One mutation carrier had enhancing brain lesions and neurological features but unknown retinopathy status. Additional systemic features included liver disease (78%), anaemia (74%), nephropathy (61%), hypertension (60%), mild Raynaud’s phenomenon (40%), and gastro-intestinal bleeding (27%). Mean (± standard deviation) age at diagnosis was 42.9 ± 8.3 years and at death 53.1 ± 9.6 years. Pathological examination revealed systemic vasculopathy with luminal narrowing and multi-laminated basement membranes. The 13 mutation carriers without retinopathy or brain lesions were on average 8 years younger (mean age: 35.1 ± 10.6 years). Of them, 54% had mild Raynaud’s phenomenon, 42% had migraine, and 23% had psychiatric disturbances. Retinal vasculopathy with cerebral leukodystrophy is an autosomal dominant systemic small-vessel disease due to specific TREX1 mutations and clinically primarily characterized by (i) visual impairment from vascular retinopathy; and (ii) neurological decline and premature death due to progressive enhancing cerebral white matter lesions. Impaired liver and kidney function, anaemia sometimes associated with gastrointestinal bleeding, hypertension, migraine, and Raynaud’s phenomenon appear to be part of the clinical spectrum as well. Penetrance seems high. Because of the pathogenetic basis and the emerging clinical picture with systemic manifestations and conspicuous absence of leukodystrophy, we renamed the disease ‘retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations’. We propose diagnostic criteria to facilitate clinical recognition and future studies. See Charidimou (doi:10.1093/aww253) for a scientific commentary on this article. Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic Manifestations is a newly recognised and often misdiagnosed neurovascular syndrome caused by mutations in TREX1. Stam et al. provide the first comprehensive clinical, pathological and radiological characterization of RVCL-S, and highlight cerebral mass lesions, impaired liver and kidney function, and premature death.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/aww217

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 174

Metadata

Authors
Stam, A. H., Kothari, P. H., Shaikh, A., Gschwendter, A., Jen, J. C., Hodgkinson, S., Hardy, T. A., Hayes, M., Kempster, P. A., Kotschet, K. E., Bajema, I. M., van Duinen, S. G., Maat-Schieman, M. L. C., de Jong, P. T. V. M., de Smet, M. D., de Wolff-Rouendaal, D., Dijkman, G., Pelzer, N., Kolar, G. R., Schmidt, R. E., Lacey, J., Joseph, D., Fintak, D. R., Grand, M. G., Brunt, E. M., Liapis, H., Hajj-Ali, R. A., Kruit, M. C., van Buchem, M. A., Dichgans, M., Frants, R. R., van den Maagdenberg, A. M. J. M., Haan, J., Baloh, R. W., Atkinson, J. P., Terwindt, G. M., & Ferrari, M. D.
Venue
Brain
Published
2016-09-06
Volume
139
Issue
11
Pages
2909-2922
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2513620161
Cited by
174
References
5
FWCI
10.30
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. https://app.cochat.ai/papers/10.1093/brain/aww217
The paper
Stam, A. H., Kothari, P. H., Shaikh, A., Gschwendter, A., Jen, J. C., Hodgkinson, S., Hardy, T. A., Hayes, M., Kempster, P. A., Kotschet, K. E., Bajema, I. M., van Duinen, S. G., Maat-Schieman, M. L. C., de Jong, P. T. V. M., de Smet, M. D., de Wolff-Rouendaal, D., Dijkman, G., Pelzer, N., Kolar, G. R., . . . Ferrari, M. D. (2016). Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. Brain. https://doi.org/10.1093/brain/aww217

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.